Routine surgery leads to catastrophic results due to medical error
Four patients admitted for routine joint replacement surgeries at Ascension Saint Thomas Hospital Midtown in Nashville, Tennessee, suffered severe complications after receiving the wrong medication. Instead of the local anesthetic bupivacaine, they were mistakenly injected with potassium phosphate. At least one patient has been left without sensation in most of her body.
Four patients admitted for routine joint replacement surgeries at Ascension Saint Thomas Hospital Midtown in Nashville, Tennessee, suffered severe complications after reportedly receiving the wrong medication. Instead of the local anesthetic bupivacaine, which was intended for spinal administration to block pain, the patients were injected with potassium phosphate. At least one patient has been left without sensation in a large part of her body. Authorities are currently investigating the circumstances of the error, as reported by Fox News.
The incident occurred during the preparation for joint replacement procedures. While spinal anesthesia is standard for such surgeries to temporarily block pain, in this case, the four patients received a different substance: potassium phosphate.
The hospital confirmed that a "medication error" occurred in the pharmacy, resulting in adverse medical reactions for the four patients. One of the victims underwent a knee replacement. According to her daughter-in-law, Christina Dorton, the surgery itself was successful, but the woman's subsequent condition was critical.
"The joint replacement went great. Her knee is fine. The rest of her body — not," Dorton told WKRN-TV. According to the family, the patient lost sensation from the sternum down. At this stage, it remains unclear whether her condition will improve or what the extent of recovery might be. Dorton stated that the treatment provided to her mother-in-law has not yet yielded the hoped-for results, emphasizing that the incident has life-altering consequences. CBS News reported that another patient claims to have been left paralyzed as well.
The hospital's president and CEO, Dr. Shubhada Jagasia, apologized to the patients and their families: "Our hearts go out to the four patients and their family members who were affected by this incident. On behalf of our leadership and care teams, I am deeply sorry for the harm caused to our patients."
Dr. Jagasia stated that hospital staff met with each family to ensure continued care and provide necessary resources. The hospital proactively reported the incident to authorities on the day it occurred and launched an internal investigation. "We identified the cause and implemented corrective safeguards," she said.
The Tennessee Bureau of Investigation has launched an inquiry into the incident following notification from the state's health regulatory commission. The investigation aims to clarify the sequence of events that led to the administration of the incorrect substance. For the families involved, the central concern remains the long-term prognosis, as the medication error has resulted in injuries that may permanently alter their lives.
